Product
Adrenomedullin
1 clinical trial
1 indication
Indication
CADASILClinical trial
A Multicenter, Single-arm, Clinical Trial of Adrenomedullin for Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and LeukoencephalopathyStatus: Completed, Estimated PCD: 2023-01-23